À propos de ce podcast
Your daily pharmaceutical news briefing — FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes, every weekday. Hosted by Alex Mercer and Maya Patel. Plus a Week in Review every Sunday synthesizing the week's biggest moves in pharma and biotech. Covering drug approvals, licensing and M&A deals, biopharma investing, and healthcare market intelligence. Smart, fast, and built for pharma and biotech professionals who need to stay ahead.…
146 épisodes · Levenswetenschappen
The Pharma Closeout | Daily Pharmaceutical and Biotech News in 15 Minutes
À propos de ce podcast
Your daily pharmaceutical news briefing — FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes, every weekday. Hosted by Alex Mercer and Maya Patel. Plus a Week in Review every Sunday synthesizing the week's biggest moves in pharma and biotech. Covering drug approvals, licensing and M&A deals, biopharma investing, and healthcare market intelligence. Smart, fast, and built for pharma and biotech professionals who need to stay ahead.…
Épisodes récents
- Week in Review | Revita Slows Regain After Tirzepatide at Six Months; Liquidia Settles With United TherapeuticsNouveau · 46 min
- Daily Roundup | Enspryng Approved for Thyroid Eye Disease as Home Injection & Omeros Refused Again by EU Panelil y a 3 jours · 12 min
- Daily Roundup | Anktiva Expands Bladder Cancer Label & Vanda's Anxiety Trial Missesil y a 4 jours · 14 min
- Daily Roundup | BioNTech's Cancer Trial Setback & Roche's Fat-Cell Betil y a 5 jours · 13 min
- Daily Roundup | Bristol's Split IPF Result & RYZ101's Phase 3 Win13 oct. · 13 min
- Week in Review | AstraZeneca's $2B Summit Bet, Merck's Eye Trial & Roche's Vamikibart Filing12 oct. · 44 min
- MDS 2026 Debrief: Two Genetic Bets Fall in Full Data & Juvmo Meets Its Payers12 oct. · 16 min
- Daily Roundup | Hovilpri Wins FDA Approval & Biohaven Licenses BHV-1300 to Ono for $80M at Closing10 oct. · 8 min
- Daily Roundup | Tecentriq Approved After dMMR Colon Cancer Surgery & Zenbexus Topline: Median PFS 42 vs 20 Months9 oct. · 10 min
- Daily Roundup | Pfizer Adds a Breast Cancer Maintenance Choice & MimiVax's Brain Cancer Vaccine Misses8 oct. · 8 min
podlinkr.com/fr/the-pharma-closeout-daily-pharmaceutical-and-bio
Pour une affiche ou une diapo.